Reduced KIAA0471 mRNA expression in Alzheimer's patients: a new candidate gene product linked to the disease?

Human Molecular Genetics
Lluïsa de YebraNicole Mahy

Abstract

Alzheimer's disease (AD) phenotype complexity raises the question whether genetic features remain unknown. Although a few percentage of patients are familial cases linked to mutations in amyloid precursor protein, presenilin 1 or presenilin 2 genes, the remainder are considered mainly sporadic late-onset cases with a complex etiology. However, changes in gene expression or other genetic features of the individual can clearly contribute to develop the illness. Consequently, in this paper we have focused on the identification of new genes, the expression of which is altered in AD. We used the technique of differential display reverse transcriptase-polymerase chain reaction (DDRT-PCR) in order to study the gene expression differences in brain tissue from patients in an advanced stage of AD. After studying medial septum and hippocampus brain areas, we found an inhibition of the KIAA0471 gene expression in three out of six AD patients, including one with a presenilin 1 gene mutation. This gene encodes for a large protein that presents, in its predicted form, 95% homology with IDN4-GGTR sequences. These results may provide significant clues for understanding the molecular mechanisms underlying septohippocampal neurodegeneration. In a...Continue Reading

References

Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Jan 1, 1995·Methods in Enzymology·P LiangA B Pardee
Nov 1, 1995·Cancer Genetics and Cytogenetics·M Debiec-RychterJ Limon
Dec 1, 1996·Annals of Neurology·T D BirdG D Schellenberg
Jan 1, 1997·Annual Review of Psychology·B J Everitt, T W Robbins
Feb 28, 1997·DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes·O OharaN Nomura
Nov 5, 1997·Annals of the New York Academy of Sciences·C L LeibsonP J Palumbo
Feb 10, 1998·DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes·N SekiO Ohara
Apr 30, 1998·Neurobiology of Aging·L M CallahanP D Coleman
Nov 24, 1999·Journal of Neuropathology and Experimental Neurology·K L NewellE T Hedley-Whyte
Feb 5, 2000·Journal of Neuroscience Research·C ColantuoniJ Pevsner
Oct 14, 2000·The Journal of Biological Chemistry·N DeGregorio-RocasolanoR Trullas
May 31, 2001·Human Genetics·J XuW B Isaacs
Dec 26, 2001·Nucleic Acids Research·Reiko KikunoOsamu Ohara
Jan 5, 2002·Neurobiology of Aging·Simon M LawsRalph N Martins
Apr 16, 2002·British Journal of Cancer·M CarterD W Ellison
Mar 14, 2003·Proceedings of the National Academy of Sciences of the United States of America·Wesley FarrisSuzanne Guenette
Jun 6, 2003·Brain Research Bulletin·A RocchiL Murri

❮ Previous
Next ❯

Citations

Oct 24, 2009·American Journal of Hypertension·Mitsutoshi OguriYoshiji Yamada

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Related Papers

Frontiers in Bioscience (Elite Edition)
Irene PiaceriS Sorbi
Current Opinion in Neurobiology
T W Kim, Rudolph E Tanzi
Annals of the New York Academy of Sciences
W AnnaertB De Strooper
© 2021 Meta ULC. All rights reserved